HNL Lab Medicine Partners with Sysmex America, Inc.

HNL Lab Medicine proudly announces a new Strategic Preferred Partnership with Sysmex America, Inc., a global leader in hematology and urinalysis solutions. This partnership aims to enhance laboratory efficiency, improve patient care, and address the ongoing challenges of the lab industry.

Warren Erdmann, Chief Operating Officer of HNL Lab Medicine, emphasized the significance of this collaboration, saying, “Sysmex is renowned for setting the gold standard in hematology and urinalysis. Through this partnership, we are well-equipped to meet the evolving challenges of the lab industry, ensuring that by collaborating with the best, we continue delivering top-tier service to both providers and patients.”

The partnership represents a natural alignment between two organizations that share a common vision of excellence in laboratory services and patient care. By leveraging Sysmex’s cutting-edge diagnostic technology and HNL Lab Medicine’s commitment to operational efficiency and clinical quality, both organizations are positioned to address the growing complexities of the lab industry. Together, we will drive innovations that enhance lab performance, improve patient outcomes, and continue setting new standards for service delivery.

Sysmex America, Inc. shares the same commitment to excellence in laboratory services. Dan Zortman, Chief Executive Officer of Sysmex America, Inc., expressed his enthusiasm for the new partnership, stating, “Sysmex America is excited to enter this new strategic partnership with HNL Lab Medicine. Together, we will meet our long-term shared business goals of enhancing lab efficiencies and delivering world-class quality and service.”

Employees of Sysmex echo his sentiment and recognize the value and potential for advancement brought by the agreement. Jeff Holmstrom, Senior Executive Officer of Sysmex America, Inc., adds, “Our partnership with HNL Lab Medicine is a great example of two trusted names in healthcare working together to improve the patient healthcare journey through innovative technology.”

The HNL Lab Medicine Strategic Preferred Partnership with Sysmex will build on the strengths of both organizations, combining cutting-edge technology with operational excellence to meet the demands of a rapidly evolving healthcare landscape. The agreement is grounded in three core pillars: delivering high-quality results, maintaining exceptional service to patients and providers, and promoting a financial model that supports continuous reinvestment in employees, facilities, and equipment.

This partnership is part of HNL Lab Medicine’s broader Strategic Preferred Partnerships Program, which focuses on creating long-term, mutually beneficial relationships with leading vendors to drive innovation, improve patient outcomes, and ensure sustainable growth.